Chris LeMasters
2019
In 2019, Chris LeMasters earned a total compensation of $3.2M as Former Executive Vice President and Chief Business Officer at Mirati Therapeutics, a 65% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,950 |
|---|---|
| Option Awards | $2,637,984 |
| Salary | $373,900 |
| Other | $2,500 |
| Total | $3,201,334 |
LeMasters received $2.6M in option awards, accounting for 82% of the total pay in 2019.
LeMasters also received $187K in non-equity incentive plan, $373.9K in salary and $2.5K in other compensation.
Rankings
In 2019, Chris LeMasters' compensation ranked 3,811th out of 13,971 executives tracked by ExecPay. In other words, LeMasters earned more than 72.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,811 out of 13,971 | 73rd |
Division Manufacturing | 1,378 out of 5,701 | 76th |
Major group Chemicals And Allied Products | 484 out of 2,200 | 78th |
Industry group Drugs | 408 out of 1,886 | 78th |
Industry Pharmaceutical Preparations | 309 out of 1,398 | 78th |
Pay ratio
| Chris LeMasters' Pay | $3,201,334 |
|---|---|
| Median Employee's Pay | $588,168 |
| Pay Ratio | 5to 1 |
In 2019, the annual total compensation of Chris LeMasters was $3,201,334.
The annual total compensation of the median employee at Mirati Therapeutics was $588,168.
The ratio of Chris LeMasters' pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 17, 2020.
LeMasters' colleagues
We found four more compensation records of executives who worked with Chris LeMasters at Mirati Therapeutics in 2019.